Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,435,336 papers from all fields of science
Search
Sign In
Create Free Account
Atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet
Known as:
ATOVAQUONE 250 mg / PROGUANIL HYDROCHLORIDE 100 mg ORAL TABLET, FILM COATED [Atovaquone and Proguanil HCl]
, atovaquone 250 MG / proguanil HCl 100 MG Oral Tablet
, ATOVAQUONE 250MG/PROGUANIL HCL 100MG TAB [VA Product]
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
24 relations
Broader (1)
Antimalarials
Atovaquone
Atovaquone / Proguanil
Crospovidone
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone–proguanil in traveller returning from Congo
Laurencie Massamba
,
Marylin Madamet
,
+10 authors
B. Pradines
Malaria Journal
2020
Corpus ID: 210862217
The drug combination atovaquone–proguanil, is recommended for treatment of uncomplicated falciparum malaria in France. Despite…
Expand
Review
2019
Review
2019
The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review.
K. Andrejko
,
Romana C Mayer
,
+4 authors
J. Gutman
Travel Medicine and Infectious Disease
2019
Corpus ID: 58539287
2018
2018
Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options
E. Meltzer
,
G. Rahav
,
Eli Schwartz
Clinical Infectious Diseases
2018
Corpus ID: 3764112
Background Atovaquone-proguanil is considered causal prophylaxis (inhibition of liver-stage schizonts) for Plasmodium falciparum…
Expand
2016
2016
Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
T. Lachish
,
M. Bar-Meir
,
N. Eisenberg
,
Eli Schwartz
Journal of Travel Medicine
2016
Corpus ID: 30032917
BACKGROUND Current guidelines recommend daily dosing of atovaquone-proguanil (AP), beginning a day before travel to endemic areas…
Expand
2014
2014
Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.
R. Tahar
,
Talleh Almelli
,
+4 authors
L. Basco
Journal of Infectious Diseases
2014
Corpus ID: 24356617
BACKGROUND Artemisinin-based combination therapies (ACTs) are recommended for the treatment of acute uncomplicated falciparum…
Expand
2008
2008
First Case of Emergence of Atovaquone-Proguanil Resistance in Plasmodium falciparum during Treatment in a Traveler in Comoros
H. Savini
,
H. Bogreau
,
+7 authors
B. Pradines
Antimicrobial Agents and Chemotherapy
2008
Corpus ID: 206698596
Atovaquone-proguanil (Malarone; GlaxoSmithKline) is now commonly used for the treatment and prophylaxis of falciparum malaria in…
Expand
2008
2008
[Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
R. Blondé
,
J. Naudin
,
+11 authors
A. Faye
Archives de pédiatrie
2008
Corpus ID: 27105079
Review
2007
Review
2007
Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
A. Boggild
,
M. Parise
,
L. Lewis
,
K. Kain
American Journal of Tropical Medicine and Hygiene
2007
Corpus ID: 32875734
The fixed dose combination of atovaquone and proguanil hydrochloride, marketed under the trade name Malarone, is the most…
Expand
2006
2006
Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark.
S. Thybo
,
I. Gjørup
,
A. Rønn
,
D. Meyrowitsch
,
I. C. Bygberg
Journal of Travel Medicine
2006
Corpus ID: 347413
BACKGROUND Previous experience with unacceptable adverse effects with mefloquine as treatment for uncomplicated Plasmodium…
Expand
1998
1998
Phase I Safety and Pharmacokinetics Study of Micronized Atovaquone in Human Immunodeficiency Virus-Infected Infants and Children
W. Hughes
,
A. Dorenbaum
,
+9 authors
The Pediatric Aids Clinical Trials Group
Antimicrobial Agents and Chemotherapy
1998
Corpus ID: 2074220
ABSTRACT A phase I dose-escalating safety and pharmacokinetic study evaluated an oral suspension of micronized atovaquone (m…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE